Clinical Pharmacogenetics of Angiotensin II Receptor Blockers in Iraq.

ABSTRACT:

Background

Clinical pharmacogenetics is a rapidly growing field that focuses on the study of genetic variations and their impact on drug metabolism, efficacy, and safety. Angiotensin II receptor blockers (ARBs) are commonly used to treat hypertension in Iraq but not all patients respond equally to these drugs.

Aim

This article aims to review the current evidence on the clinical pharmacogenetics of ARBs in Iraq and its implications for personalized medicine.

Materials and methods

We conducted a literature review of studies on the genetic variations that affect the response to ARBs in Iraq. We also reviewed the prevalence of these genetic variants in the Iraqi population and discussed the potential clinical implications for personalized medicine.

Results

The most

SUBMITTER: Al-Hussaniy HA 

PROVIDER: S-EPMC10496849 | biostudies-literature | 2023 Jul-Sep

REPOSITORIES: biostudies-literature